Peptinovo Biopharma
Ann Arbor
About Peptinovo Biopharma
Peptinovo develops novel nanoparticles targeting anti-cancer drugs to tumors for improved therapeutic outcomes and reduced side effects. The company has strong knowledge of the drug discovery and development process gained during the many years the founders worked for large pharmaceutical companies.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $17.6M
- Funding stage: Early Stage Venture
- Last round: Series A (Dec 2024)
- Website: peptinovo.com
Industries & Categories
Biopharma, Biotechnology, Therapeutics
Canonical: https://fsome.com/organization/peptinovo-biopharma-81038 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.